UNSPSC 51433910: Palonidipine

This classification denotes a calcium channel blocker with the molecular formula C29H34FN3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FMS4X67Q96, chemically known as (- )-3-(benzylmethyl-amino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate. but generally known as palonidipine, which bears US NIH Compound Identifier 119154. European Medicines Agency schedules Palonidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09592MIG.

UNSPSC 51433910 Palonidipine (Commodity) names a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code reflects a much broader scope: municipalities are soliciting sealed bids for advanced life support medications used by emergency medical services and fire departments. The City of Tampa's April 2026 solicitation for Advanced Life Support Medications (Bid No. 26P00188) demonstrates the actual purchasing pattern — the bid covers four medication line items (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials) used in emergency care, with unit quantities ranging from 330 to 1,810 units and a one-year contract term. These purchases are driven by municipal fire and EMS departments managing rotating inventory with strict expiration dates (minimum nine months from acceptance) and rapid delivery windows (ten calendar days from order). Vendors must supply complete safety documentation including OSHA-compliant Safety Data Sheets and maintain product warranties for defects; the City reserves the right to extend the initial one-year term through multiple renewal and short-term extension options. Municipal purchasing departments and fire departments represent the primary issuing bodies under this code.

The geographic footprint reflects activity in Florida, where Tampa Fire Rescue's procurement drove the City of Tampa's April 2026 IFB with a $40,000 estimated value and a response date of April 8, 2026. The solicitation includes a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation not to exceed $10,000, though no SLBE subcontracting goals were established. Award will go to the lowest responsive, responsible bidder within 120 days of bid opening, and the City reserves the right to award by division or in aggregate, or to cancel with ten days' written notice for cause or thirty days' written notice without cause. Accessibility conformance to WCAG 2.2 Level AA and Section 508 standards is required for all proposers.